Prof. Dr. med. Fabian Müller

Department of Medicine 5 – Haematology and Oncology Professur für CAR-T-Zell-Therapie

The EMT transcription factor ZEB1 blocks osteoblastic differentiation in bone development and osteosarcoma (2021) Ruh M, Stemmler M, Frisch I, Fuchs K, van Roey R, Kleemann J, Roas M, et al. Journal article Neue antikörperbasierte Therapien in der Hämatologie (2021) Müller F Journal article, Review article Triton X-114 and Amine-Based Wash Strategy Reduces Lipopolysaccharides to FDA Limit and Achieves Purer, More Potent Recombinant Immunotoxin (2021) George R, Gsottberger F, Ammon AM, Wendland K, Mellenthin L, Mackensen A, Müller F Journal article A murine, myc-driven lymphoma model expressing human CD22 enables testing of targeted therapies and their effects on tumor immune microenvironment (2020) Gsottberger F, Brandl C, Petkovic S, Emmerich C, Nitschke L, Mackensen A, Müller F Conference contribution Blocking counter regulation of unfolded protein response by targeted protein synthesis inhibition produces highly synergistic cell death in several cancer entities (2020) Müller F, Gsottberger F, Meier C, Petkovic S, Krumbholz M, Metzler M, Mackensen A Conference contribution A human CD22 transgenic, myc-driven lymphoma model to test effects of targeted therapies on lymphoma immune microenvironment in immunecompetent mice (2019) Wagner F, Brandl C, Petkovic S, Emmerich C, Nitschke L, Mackensen A, Müller F Conference contribution 2-Deoxyglucose induced unfolded protein response enhances efficacy of immunotoxin Moxetumomab pasudotox against lymphoma and leukemia xenografts (2019) Wagner F, Meier C, Krumbholz M, Metzler M, Mackensen A, Müller F Conference contribution Development of pseudomonas exotoxin based Duotoxins for the treatment of hematologic malignancies (2019) Ammon AM, Emmerich C, Mellenthin L, Mackensen A, Müller F Conference contribution Myc-Driven, Primary Mouse Lymphoma Expressing Human CD22 Are Highly Infiltrated By Syngeneic Immune Cells and Provide a Unique Model to Test CD22-Targeted Therapies (2018) Wagner F, Brandl C, Emmerich C, Mackensen A, Nitschke L, Müller F Conference contribution Domain II of Pseudomonas Exotoxin Is Critical for Efficacy of Bolus Doses in a Xenograft Model of Acute Lymphoblastic Leukemia (2018) Müller F, Cunningham T, Beers R, Bera TK, Wayne AS, Pastan I Journal article